Aristotle University Of Thessaloniki (AUTH)
ΚΛΙΝΙΚΗ ΕΡΕΥΝΑ ΤΗΣ ΑΝΤΙΕΠΙΛΗΠΤΙΚΗΣ ΔΡΑΣΗΣ ΤΗΣ ΔΕΞΤΡΟΜΕΘΟΡΦΑΝΗΣ ΣΕ ΑΣΘΕΝΕΙΣ ΜΕ ΑΝΘΕΚΤΙΚΗ ΣΤΗ ΘΕΡΑΠΕΙΑ ΕΠΙΛΗΨΙΑ.
Abstract
dc:descriptionDEXTROMETHORPHAN IS A NON-NARCOTIC MORPHINAN DERIVATIVE WIDELY USED AS AN ANTITUSSIVE FOR ALUST 40 YEARS. RECENTLY IT WAS ATTRACTED ATTENTTION DUE TO ITS AUNCONVULSANT AND NEUROPROTECTIVE PROPERHES WHICH ARE ATTRIBUTED TO DIVERSE MECHANISM INCLUDING NMDA ANTAGONISM. IN THIS DISSERTATION WE UNDERTOOK A LATE PHASE I CLINICAL TRIAL OF DETROMETHORPHAN IN PATIENTS WITH PARHIAL PHARMACORESISTAN EPILEPSIES. THE OBJECHVES OF TRIAL INCLUDED HE DERMINATION OF THE DRUGS PHARMACOKINEHCS, NE PRELIMINANY EVALUATION OF THE DRUGS EFFICACY AND TOXICITY ANDA DEFINITION OF A CONCETRANOU RANGE WHICH CAN BE SAFELY ATTAINED IN FURTHER STUDIES. SIXTEEN PAHEN ENTERED THE TRIL. THE PHARMAROKINETICS OF THE PARENT DRUG AND ITS PRINCIPAL METASOLITES WERE DESCRIBED IN DETAIL WITH REGARD TO ITS EFFICARY AND TOXICITY, IT IS CONCLUDED THAT DEXTROMETHORPHAN IS POTENHALLY EFHCACIONS AGAIST PHORMACORESISTANT PARHOL SEIZURTS CAUSINS SIGNIFIACANT SIDE EFFECTS. REGARDINS THE LAST OBJECTIVE IT HAS BEEN SHOWN HISH DEXTROMETHORPHAN PLASMA LEVELS (NP TO 150.2 NG/ML), WHICH CORSPOND TO BRAIN CONCENTRATIONS SIMILAR TO THE IN VITRO ANTIEPILEPHE LEVELS, CAN BE SAFELY ATTAINED IN EPILEPHC PARIENS.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 1996
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Κιμισκίδης, Βασίλειος
- Kimiskidis, Vasilios
Subjects
dc:subject × 17Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/9142